SCHEMBL24257934

SCHEMBL24257934

CCc1ccc(CCOc2ccc(S(=O)(=O)Nc3ncc(C(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)cn3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.41
PKM P14618 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
CA2 P00918 1/20 0.39
HTT P42858 1/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SGMS1 Q86VZ5 4/20 0.38
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
TBXA2R P21731 1/20 0.38
TBXAS1 P24557 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
THRB P10828 1/20 0.37
MCL1 Q07820 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257984 0.93 CA2 (0.41) KDM4ESMN1; SMN2PKMTDP1CA2
SCHEMBL24257905 0.93 NPC1 (0.42) SMN1; SMN2PKMTDP1CA2HTT
SCHEMBL24257849 0.91 HDAC3 (0.43) KDM4ESMN1; SMN2PKMCA2ALDH1A1
SCHEMBL22080442 0.90 SMN1; SMN2 (0.39) SMN1; SMN2PKMTDP1CA2ALDH1A1
SCHEMBL24257961 0.90 SMN1; SMN2 (0.39) SMN1; SMN2PKMTDP1CA2ALDH1A1
SCHEMBL24257953 0.88 SMN1; SMN2 (0.40) SMN1; SMN2PKMTDP1CA2ALDH1A1
SCHEMBL24257940 0.88 AKT1 (0.42) KDM4ESMN1; SMN2PKMTDP1CA2
SCHEMBL24257854 0.88 SMN1; SMN2 (0.41) KDM4ESMN1; SMN2PKMTDP1CA2
SCHEMBL24257935 0.87 SMN1; SMN2 (0.40) KDM4ESMN1; SMN2PKMTDP1CA2
SCHEMBL24257941 0.86 TDP1 (0.54) SMN1; SMN2PKMTDP1CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048968-A1 INSULIN CONJUGATES SANOFI (FR) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048968-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R KDM4E 3938/4885SMN1; SMN2 1332/4885PKM 1743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.